Clinical Trial Update: Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing mirabegron to solifenacin for pharmacologic effect in female overactive bladder syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Mirabegron (mirabegron)
• Solifenacin (solifenacin)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Overactive Bladder Syndrome | Phase 3 | Status: UNKNOWN